GGrantIndex
Sort

130,381 grants matching hiv

Herpes Simplex Immunotherapeutic Vaccine

$999,845
Sean M. Sullivan · Vical, Inc. · R42 · FY2009 · AI

Rapid, Near-Tranfusion Test for Bacteria in Platelets Units

$999,842
Andrew E. Levin · Immunetics, Inc. · R44 · FY2013 · HL

Advancing a Mucosal HSV-2 Vaccine Towards Clinical Trials

$999,834
Kejian Yang · Biomedical Research Models, Inc. · R44 · FY2014 · AI

Midwest Developmental Center for AIDS Research (D-CFAR)

$999,831
Elvin H. Geng · Washington University · P30 · FY2024 · AI

Anal HPV Infection and ASIL in HIV+ and HIV- Women

$999,803
University Of California San Francisco · R01 · FY2004 · CA

Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery

$999,781
Barton F Haynes · Duke University · UM1 · FY2016 · AI

Induction of protective b-cell responses to HIV-1

$999,781
Barton F Haynes · Duke University · UM1 · FY2016 · AI

'Infrastructure For Community-Linked Research To Address Disparities In HIVAIDS

$999,777
Marguerita A Lightfoot · University Of California, San Francisco · RC4 · FY2010 · MD

Point-of-Care Rapid RNA test for HIV

$999,743
Hyundae Cho · Crosslife Technologies, Inc. · R44 · FY2018 · AI

Herpes Simplex Immunotherapeutic Vaccine

$999,688
Sean M. Sullivan · Vical, Inc. · R42 · FY2008 · AI

Enhanced MDx: a computational model to optimize pre-analytical pathogen isolation from whole blood

$999,676
Cass T Miller · Redbud Labs, Inc. · R42 · FY2022 · GM

Immune Regulation in Mycobacterial and Fungal Infections

$999,676
Daniel Barber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI

Development of AAV vectors for long-term expression of eCD4-Ig

$999,675
Michael David Alpert · Emmune, Inc · R44 · FY2019 · AI

SOUTH AFRICA MRC HIV PREVENTION TRIALS UNIT

$999,652
Medical Research Council Of South Africa · U01 · FY2000 · AI

Conformational Stabilization of the HIV-1 Env Trimer

$999,646
Christopher Marshall · Avatar Medical, Llc · R44 · FY2015 · AI

Conformational Stabilization of the HIV-1 Env Trimer

$999,641
Christopher Marshall · Avatar Medical, Llc · R44 · FY2013 · AI

Coordinating Center for the Pediatric HIV/AIDS Cohort Study II

$999,613
Russell Barrett Van Dyke · Tulane University Of Louisiana · U01 · FY2011 · HD

Novel Spectinamide Antibiotics for the Treatment of MDR/XDR Tuberculosis

$999,559
Michelle M. Butler · Microbiotix, Inc · R44 · FY2019 · AI

The Effects of Prenatal Cocaine Exposure in Adolescence

$999,553
Sonia Minnes · Case Western Reserve University · R01 · FY2009 · DA

Dendritic Cell-Targeted HIV Vaccine Product

$999,540
Tibor Keler · Celldex Therapeutics, Inc. · R44 · FY2014 · AI

Development of AAV vectors for long-term expression of eCD4-Ig

$999,443
Michael David Alpert · Emmune, Inc · R44 · FY2020 · AI

Core D: Clinical Research Core

$999,419
Ighovwerha Ofotokun · Emory University · P30 · FY2019 · AI

Lymphocyte Dynamics

$999,413
William Paul · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI

Miami Pediatric AIDS Clinical Trials Unit

$999,382
University Of Miami School Of Medicine · U01 · FY2005 · AI

Mechanisms Of Immune Mediated Restriction Of HIV Replication In LTNP

$999,369
Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI